claim
Transcription factor-mediated cellular reprogramming for cancer treatment faces challenges related to cost, delivery efficiency, and in vivo procedures, leading to a need for alternative methods due to safety and effectiveness concerns regarding genetic manipulations.

Authors

Sources

Referenced by nodes (1)